Skip to search formSkip to main contentSkip to account menu

ardisiacrispin A

Known as: 3 beta-O-(beta-D-xylopyranosyl-(1-2)-O-beta-D-glucopyranosyl-(1-4)-(O-beta-D-glucopyranosyl-(1-2))-alpha-L-arabinopyranosyl)-16 alpha-hydroxy-13 beta,28-epoxyolean-30-al, Oleanan-29-al, 13,28- epoxy-3-((O-beta-D-glucopyranosyl-(1-2)-O-(O-beta-D-xylopyranosyl-(1-2)-beta-D-glucopyranosyl-(1-4))-alpha-L-arabinopyranosyl)oxy)-16-hydroxy-, (3beta,16alpha,20beta)- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
: As overall conclusions from this study, and the two preceding comparable trials in which TcPO2 was measured in patients with (8… 
1987
1987
1987
1987
In a prospective 6 weeks study, done in 3 phlebology practices on 107 patients presenting an acute leg ulcer, we compared the… 
1987
1987
In a double-blind study the effect of a high dosage of O-(beta-hydroxyethyl)-rutosides (HR) was tested in women taking oral… 
1985
1985
Adriamycin (Adriablastine), administered weekly at the dose of 5 mg/kg i.p. for 3 weeks in rats, produced a general decrease of… 
1981
1981
The effect of three different oral doses of O-(beta-hydroxyethyl)-rutosides (HR, Venoruton) on the skin capillary resistance (CR…